Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,917 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy.
Meacci E, Nachira D, Congedo MT, Ibrahim M, Pariscenti G, Petrella F, Casiraghi M, De Stefani A, Del Regno L, Peris K, Triumbari EKA, Schinzari G, Rossi E, Petracca-Ciavarella L, Vita ML, Chiappetta M, Siciliani A, Peritore V, Manitto M, Morelli L, Zanfrini E, Tabacco D, Calabrese G, Bardoni C, Evangelista J, Spaggiari L, Margaritora S. Meacci E, et al. Among authors: rossi e. Cancers (Basel). 2023 Apr 25;15(9):2462. doi: 10.3390/cancers15092462. Cancers (Basel). 2023. PMID: 37173927 Free PMC article.
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer.
Rossi E, Bagalà C, Inzani F, Leoncini E, Brunelli C, Lanza P, Basso M, Mattiucci GC, Cassano A, Rindi G, Barone C, Schinzari G. Rossi E, et al. In Vivo. 2017 Sep-Oct;31(5):833-840. doi: 10.21873/invivo.11136. In Vivo. 2017. PMID: 28882948 Free PMC article.
Neoadjuvant Chemotherapy for Patients with Muscle-invasive Urothelial Bladder Cancer Candidates for Curative Surgery: A Prospective Clinical Trial Based on Cisplatin Feasibility.
Schinzari G, Monterisi S, Pierconti F, Nazzicone G, Marandino L, Orlandi A, Racioppi M, Cassano A, Bassi P, Barone C, Rossi E. Schinzari G, et al. Among authors: rossi e. Anticancer Res. 2017 Nov;37(11):6453-6458. doi: 10.21873/anticanres.12100. Anticancer Res. 2017. PMID: 29061832
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma.
Rossi E, Maiorano BA, Pagliara MM, Sammarco MG, Dosa T, Martini M, Rindi G, Bria E, Blasi MA, Tortora G, Schinzari G. Rossi E, et al. Front Oncol. 2019 Apr 5;9:232. doi: 10.3389/fonc.2019.00232. eCollection 2019. Front Oncol. 2019. PMID: 31024839 Free PMC article.
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions.
Iacovelli R, Ciccarese C, Schinzari G, Maiorano BA, Rossi E, Pierconti F, Bassi PF, Bria E, Tortora G. Iacovelli R, et al. Among authors: rossi e. Crit Rev Oncol Hematol. 2019 Jul;139:83-86. doi: 10.1016/j.critrevonc.2019.05.005. Epub 2019 May 11. Crit Rev Oncol Hematol. 2019. PMID: 31112886 Review.
Pembrolizumab as first-line treatment for metastatic uveal melanoma.
Rossi E, Pagliara MM, Orteschi D, Dosa T, Sammarco MG, Caputo CG, Petrone G, Rindi G, Zollino M, Blasi MA, Cassano A, Bria E, Tortora G, Schinzari G. Rossi E, et al. Cancer Immunol Immunother. 2019 Jul;68(7):1179-1185. doi: 10.1007/s00262-019-02352-6. Epub 2019 Jun 7. Cancer Immunol Immunother. 2019. PMID: 31175402 Free PMC article.
2,917 results